InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the detailed record of transactions filed by Wasson Gregory d, Director. Officer active across 3 companies, notably P3 Health Partners Inc.. Aggregated, 11 disclosures have been logged. History available since 30 June 2021. The latest transaction was filed on 6 August 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Wasson Gregory d
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
2,000 股0Class A Common
StockSEC:0001188827-26-000002:0
2,000 股0Class A Common
StockSEC:0001628280-25-039352:0
9,868 股0Common StockSEC:0001628280-25-031015:0
10,061 股0Common StockSEC:0001628280-24-027714:0
216,561 股0Class A Common
StockSEC:0001628280-24-002236:0
4,637 股0Common StockSEC:0001628280-23-029924:0
657 股0Common StockSEC:0001628280-23-010321:0
409 股0Common StockSEC:0001628280-23-000216:0
334 股0Common StockSEC:0001628280-22-025808:0
6,843,525 股Class A Common StockSEC:0000899243-21-039474:0
407 股0Common StockSEC:0001213900-21-035083:0
11 条申报中的 11 条
About Wasson Gregory d
Gregory D. Wasson serves as a Director at P3 Health Partners Inc., OptimizeRx Corp, and Foresight Acquisition Corp. In this role, he contributes to strategic decision-making and oversight of the activities of all three companies. Gregory brings valuable expertise in health and business development, contributing to the leadership of these companies. His commitment to innovation is an asset to all the organizations.
